BE799331A - Procede d'obtention de formes pharmaceutiques retard - Google Patents

Procede d'obtention de formes pharmaceutiques retard

Info

Publication number
BE799331A
BE799331A BE130945A BE130945A BE799331A BE 799331 A BE799331 A BE 799331A BE 130945 A BE130945 A BE 130945A BE 130945 A BE130945 A BE 130945A BE 799331 A BE799331 A BE 799331A
Authority
BE
Belgium
Prior art keywords
pharmaceutical forms
obtaining delayed
delayed pharmaceutical
obtaining
forms
Prior art date
Application number
BE130945A
Other languages
English (en)
French (fr)
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BE799331A publication Critical patent/BE799331A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
BE130945A 1972-05-10 1973-05-09 Procede d'obtention de formes pharmaceutiques retard BE799331A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7216616A FR2183546B1 (xx) 1972-05-10 1972-05-10

Publications (1)

Publication Number Publication Date
BE799331A true BE799331A (fr) 1973-11-09

Family

ID=9098254

Family Applications (1)

Application Number Title Priority Date Filing Date
BE130945A BE799331A (fr) 1972-05-10 1973-05-09 Procede d'obtention de formes pharmaceutiques retard

Country Status (17)

Country Link
US (1) US3950508A (xx)
JP (1) JPS5526124B2 (xx)
AR (1) AR203268A1 (xx)
BE (1) BE799331A (xx)
CA (1) CA1041906A (xx)
DD (1) DD104027A5 (xx)
DE (1) DE2323686A1 (xx)
DK (1) DK137706B (xx)
FI (1) FI56623C (xx)
FR (1) FR2183546B1 (xx)
GB (1) GB1421964A (xx)
HU (1) HU168307B (xx)
IL (1) IL42232A (xx)
IN (1) IN139518B (xx)
NL (1) NL158388B (xx)
OA (1) OA04380A (xx)
ZA (1) ZA733188B (xx)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4985017A (en) * 1981-07-13 1991-01-15 Alza Corporation Parenteral therapeutical system comprising drug cell
EP0094116A3 (en) * 1982-05-06 1984-08-01 The Procter & Gamble Company Therapeutic granules
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
DE3435325A1 (de) * 1983-04-09 1986-04-17 Nikken Chemicals Co., Ltd., Tokio/Tokyo Langzeitwirkende theophyllin-tablette und verfahren zu deren herstellung
JPH0759502B2 (ja) * 1983-05-31 1995-06-28 チヨ−ン グツク ヤ−ン 調節放出型剤形用の乾式直接圧縮組成物
JPS60104804A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
JPS60104805A (ja) * 1983-11-09 1985-06-10 Nippon Ferrite Ltd エア抜き装置
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
US4772475A (en) * 1985-03-08 1988-09-20 Yamanouchi Pharmaceutical Co., Ltd. Controlled-release multiple units pharmaceutical formulation
GB8521350D0 (en) * 1985-08-28 1985-10-02 Euro Celtique Sa Analgesic composition
US4810501A (en) * 1986-06-17 1989-03-07 Warner-Lambert Company Sustained release pharmaceutical preparations
US4994276A (en) * 1988-09-19 1991-02-19 Edward Mendell Co., Inc. Directly compressible sustained release excipient
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
US4851226A (en) * 1987-11-16 1989-07-25 Mcneil Consumer Products Company Chewable medicament tablet containing means for taste masking
US5135757A (en) * 1988-09-19 1992-08-04 Edward Mendell Co., Inc. Compressible sustained release solid dosage forms
US5169639A (en) * 1988-09-19 1992-12-08 Edward Mendell Co., Inc. Controlled release verapamil tablets
US5128143A (en) * 1988-09-19 1992-07-07 Edward Mendell Co., Inc. Sustained release excipient and tablet formulation
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
BE1004461A5 (fr) * 1991-01-30 1992-11-24 Wellcome Found Comprimes dispersables dans l'eau.
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5472711A (en) * 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
EP0670716B1 (en) * 1992-11-30 2003-03-26 Kv Pharmaceutical Company Tastemasked pharmaceutical materials
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
FR2760190B1 (fr) * 1997-02-28 1999-04-09 Adir Composition pharmaceutique pour la liberation programmee de dexfenfluramine
IN186245B (xx) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
RU2241458C2 (ru) 1997-12-22 2004-12-10 Эро-Селтик, С.А. Комбинации агонист/антагонист опиоида
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
AUPQ573300A0 (en) 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
JP4522652B2 (ja) 2001-05-11 2010-08-11 エンドー ファーマシューティカルズ， インコーポレイティド 乱用防止制御放出オピオイド投薬形態
JP4620355B2 (ja) 2002-04-05 2011-01-26 ユーロ−セルティーク エス．エイ． 活性化合物の持続、不変及び独立放出のためのマトリクス
CA2531637A1 (en) * 2003-07-23 2005-02-03 L. Perrigo Company Cellulosic fiber containing composition
JP5032300B2 (ja) * 2004-03-22 2012-09-26 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 界面活性剤を含有している、リパーゼを含有する生成物の、とりわけパンクレアチンの経口医薬組成物
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
AP2274A (en) * 2005-01-28 2011-08-19 Euro Celtiques Sa Alcohol resistant dosage forms.
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
RU2413532C2 (ru) 2005-07-29 2011-03-10 Зольвай Фармасьютиклз Гмбх Способ получения стерилизованного порошкообразного панкреатина
US11266607B2 (en) * 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) * 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
PE20110422A1 (es) * 2008-07-07 2011-07-01 Euro Celtique Sa Composicion farmaceutica que comprende antagonistas opioides
PT2405915T (pt) 2009-03-10 2019-01-29 Euro Celtique Sa Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
AU2014295042B2 (en) 2013-07-23 2017-03-30 Mundipharma Pty Limited A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993836A (en) * 1958-02-20 1961-07-25 Dow Chemical Co Sustained release tablets
US2980589A (en) * 1958-09-12 1961-04-18 American Cyanamid Co Process for producing anhydrous granulation of a medicinally active waterlabile powder
US3079303A (en) * 1958-12-11 1963-02-26 Smith Kline French Lab Basic tablet granulation and process of using same
FR1473805A (fr) * 1959-10-01 1967-03-24 Merck & Co Inc Véhicule pharmaceutique
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
US3453360A (en) * 1966-04-27 1969-07-01 Abbott Lab Universally useful stock material for manufacturing plastic dosage units by compression tableting processes
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3507952A (en) * 1968-12-20 1970-04-21 Smithkline Corp Sustained release bolus for animal husbandry
GB1359643A (en) * 1970-09-28 1974-07-10 Controlled Medications Controlled release medicament
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions

Also Published As

Publication number Publication date
OA04380A (fr) 1980-02-15
DD104027A5 (xx) 1974-02-20
DK137706C (xx) 1982-11-15
CA1041906A (fr) 1978-11-07
IN139518B (xx) 1976-06-26
HU168307B (xx) 1976-03-28
FI56623C (fi) 1980-03-10
IL42232A (en) 1976-08-31
DK137706B (da) 1978-04-24
AU5531473A (en) 1974-11-07
AR203268A1 (es) 1975-08-29
FR2183546A1 (xx) 1973-12-21
NL158388B (nl) 1978-11-15
NL7306422A (xx) 1973-11-13
IL42232A0 (en) 1973-07-30
JPS5526124B2 (xx) 1980-07-11
ZA733188B (en) 1975-01-29
GB1421964A (en) 1976-01-21
DE2323686A1 (de) 1973-11-22
US3950508A (en) 1976-04-13
FR2183546B1 (xx) 1975-06-20
JPS4992217A (xx) 1974-09-03
FI56623B (fi) 1979-11-30

Similar Documents

Publication Publication Date Title
BE799331A (fr) Procede d'obtention de formes pharmaceutiques retard
BE804664A (fr) Procede de preparation continue de solutions aqueuses de cobalt-carbonyles
FR2284604A1 (fr) Procede de preparation d'a-tocopherol
RO63025A (fr) Procede pour la preparation des aminophenyletanolamines
BE789586A (fr) Procede pour la preparation de 3,4,5-trimethoxy-benzaldehyde
BE808733A (fr) Procede de preparation de cyclohexane-diones-1,3
RO62817A (fr) Procede pour la preparation des 1-acyle-3-aminosulfonyle-2-benzimidazoles
RO62914A (fr) Procede pour la preparation des derives des 2-alkylaminodihydropyridines
BE807434A (fr) Procede pour la preparation de 3,6-dihalo-diphenyl-alcanes
RO62622A (fr) Procede pour la preparation des 1-hydroxy-2-pyridones
BE800599A (fr) Procede de preparation d'amides dimethyl-2,5 furanne- carboxyliques-3
BE808316A (fr) Procede pour la preparation de beta-alcoxy-omega-lactames
BE806277A (fr) Procede pour la preparation de cycloalcanones et de cycloalcanols
RO62896A (fr) Procede pour la preparation des 7-aminocephalosporines
RO64465A (fr) Procede d'obtention de la n-diethyleaminoethyle-2-methoxy-4-amino-5-chlorebenzamide
RO62902A (fr) Procede pour la preparation des derives d'oxindole
RO72164A (ro) Procedeu pentru prepararea unor peniciline
RO71937A (ro) Procedeu de preparare a unor derivati de benzodioxol
RO71515A (ro) Procedeu pentru obtinerea unor derivati ai bis-piperazino-androstanului
RO63005A (fr) Procede pour la preparation des carbamoilsulfoxydes
BE802600A (fr) Procede pour la preparation de substances ameres
BE807087A (fr) Procede pour la preparation de thiazolines-(3)
RO63583A (fr) Procede pour la preparation des 2-amino-4-h-pyrannes
RO63441A (fr) Procede pour la preparation des 2-benzoyl-3-aminopyridines
BE796458A (fr) Procede perfectionne de preparation de cephalospines

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: LABORATOIRES SERVIER

Effective date: 19920531